These findings suggest that prokineticin 2 could serve as a valuable prognostic biomarker for sepsis, underscoring its crucial role in reducing sepsis-induced mortality and providing a novel approach for sepsis immunotherapy [131]. Here, PROK2 is linked to Sepsis.